不妊治療市場：製品タイプ、治療タイプ、診断、エンドユーザー別-2025-2030年世界予測

不妊治療市場は、2024年には59億3,000万米ドルとなり、2025年には65億8,000万米ドル、CAGR 11.32%で成長し、2030年には113億米ドルに達すると予測されています。

急速に進歩する今日の医療分野において、不妊治療は無数の個人と家族にとって希望の光となっています。この市場は、単に規模が拡大しているだけでなく、最先端の技術革新と患者ケアの水準向上により、複雑さを増して進化しています。ここ数年の間に、新しい技術と生殖医療に対する深い理解が融合し、診断と治療の実践に変革がもたらされました。この変革は、治療サイクルの成功率を大幅に向上させた低侵襲手技、最適化された検査技術、および強化されたモニタリングツールの採用の増加に顕著に表れています。

パーソナライゼーションと患者体験の向上に世界的に焦点が当てられるようになったことで、不妊症への取り組みがより総合的なアプローチになりました。医療提供者と研究者は、伝統的な方法と新しい科学的発見を組み合わせた統合的な治療経路を絶えず模索しており、その結果、有効性が向上し、患者の精神的・経済的負担が軽減されています。このエグゼクティブサマリーでは、このダイナミックな分野をさらに掘り下げるために、重要な市場動向を明らかにし、主なセグメンテーションの結果を概説し、行動可能な提言をまとめて提示します。

不妊治療を再定義する変革的シフト

ここ数年、不妊治療を取り巻く環境は大きく変化しています。画像診断システムやレーザー機器などの分野における技術導入は、より正確な診断と的を絞った介入への道を開いた。最新のクライオシステムや先進的なインキュベーターの設計は、保存プロセスに革命をもたらし、その後の治療サイクルにおいてより高い成功率を保証しています。このような進歩は、臨床医が不快感を最小限に抑え、回復時間を短縮する技術を好むようになり、患者中心の治療がより重視されるようになったことで後押しされました。

さらに、規制の枠組みや研究資金の増加が、革新的な治療アプローチの採用を加速させています。新たな技術が日常臨床に溶け込むにつれ、高度に専門化された診断ツールや治療法への移行が目に見えています。この転換は、患者ケアの質を高めるだけでなく、業界内の競合ダイナミズムの変化をも引き起こしています。意思決定者は現在、卓越したオペレーションを確保しながら技術的進化を受け入れるという岐路に立たされており、現在の市場の需要に戦略的に適応することが不可欠となっています。

市場を形成する詳細なセグメンテーションの洞察

市場を詳細に評価すると、不妊治療業界における戦略的意思決定を促進する明確なセグメンテーションパターンが明らかになります。製品タイプ別では、アクセサリー、機器、メディア・消耗品に焦点を当てています。特に機器については、クライオシステム、ガスアナライザー、イメージングシステム、インキュベーター、レーザーシステム、マイクロマニピュレーターシステム、顕微鏡、卵子吸引ポンプ、精子アナライザーシステム、精子分離装置について包括的に詳細に調査しています。さらに、凍結保存培地や培養培地などの培地・消耗品は、治療手順中の高い品質と生存率を維持する上で極めて重要な役割を果たします。

治療タイプに基づくセグメンテーションにより、さらに詳細な洞察が明らかになります。市場分析では、特に研究されている子宮頸管内、子宮腔内、子宮内方法による人工授精について調査しています。生殖補助医療（ART）は、胚凍結保存、体外受精（IVF）、卵細胞質内精子注入法（ICSI）、着床前遺伝子診断（PGD）のレンズを通して検討されます。同様に、不妊治療には、クエン酸クロミフェン、ゴナドトロピン、レトロゾール、メトホルミンなどの標的不妊治療薬や、子宮鏡検査、腹腔鏡検査、子宮筋腫摘出術、子宮瘤修復術、子宮瘤摘出術などの不妊手術が含まれます。さらに診断に基づくセグメンテーションでは、子宮卵管造影検査と排卵検査で評価される女性不妊症と、血液検査、精液分析、精巣生検で評価される男性不妊症の微妙な違いが区別され、エンドユーザーにはクライオバンク、不妊クリニック、病院、調査機関が含まれます。この包括的なセグメンテーションの枠組みは、市場理解と戦略立案のための強固な基盤を提供します。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • ライフスタイルの変化と出産の遅れによる不妊症の増加
    • 不妊治療研究開発への投資と資金の増加
    • 生殖補助医療に対する認識と受容の向上
  • 抑制要因
    • 不妊治療に伴う高額な費用と不妊治療プロトコルのばらつき
  • 機会
    • 個々の患者の生殖能力プロファイルに合わせた個別化医療アプローチの進歩
    • 不妊治療の相談と治療へのアクセスを拡大するための遠隔医療の導入
  • 課題
    • 不妊治療に関する認識と教育の欠如
• 市場セグメンテーション分析
  • 製品タイプ：不妊治療における機器の重要性の高まり
  • エンドユーザー：不妊治療の包括的な範囲により、不妊治療クリニックへの関心が高まっています。
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社会
  • 技術的
  • 法律上
  • 環境

第6章 不妊治療市場：製品タイプ別

• アクセサリー
• 装置
  • クライオシステム
  • ガス分析装置
  • イメージングシステム
  • インキュベーター
  • レーザーシステム
  • マイクロマニピュレーターシステム
  • 顕微鏡
  • 卵子吸引ポンプ
  • 精子分析システム
  • 精子分離装置
• メディアと消耗品
  • 凍結保存媒体
  • 文化メディア

第7章 不妊治療市場治療の種類別

• 人工授精
  • 子宮頸管内授精
  • 卵管内人工授精
  • 子宮内人工授精
• 生殖補助医療（ART）
  • 胚凍結保存
  • 体外受精（IVF）
  • 卵細胞質内精子注入法（ICSI）
  • 着床前遺伝子診断（PGD）
• 不妊治療薬
  • クロミフェンクエン酸塩
  • ゴナドトロピン
  • レトロゾール
  • メトホルミン
• 不妊治療手術
  • 子宮鏡検査
  • 腹腔鏡検査
  • 子宮筋腫摘出術
  • 静脈瘤の修復
  • 静脈瘤切除術

第8章 不妊治療市場診断別

• 女性の不妊症
  • 子宮卵管造影検査（HSG）
  • 排卵検査
• 男性不妊
  • 血液検査
  • 精液検査
  • 精巣生検

第9章 不妊治療市場：エンドユーザー別

• クライオバンク
• 不妊治療クリニック
• 病院
• 調査機関

第10章 南北アメリカの不妊治療市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の不妊治療市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの不妊治療市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析, 2024
• FPNVポジショニングマトリックス, 2024
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• AbbVie Inc.
• Bayer AG
• City Fertility Centre
• CooperSurgical, Inc.
• Cryoport Systems, LLC.
• Embryolab
• EQUIPO IVI, S. L.
• Ferring International Center S.A.
• FUJIFILM Irvine Scientific, Inc.
• Genea Group
• IVI AMERICA, LLC
• Merck KGaA
• Monash IVF
• New Hope Fertility Clinic
• Nova IVF Fertility
• NOW-fertility SA
• Ovum Woman and Child specialty Hospital
• ReproTech LLC
• Seegene, Inc.
• TMRW Life Sciences, Inc.
• Vitrolife Sweden AB

LIST OF FIGURES

• FIGURE 1. INFERTILITY TREATMENT MARKET MULTI-CURRENCY
• FIGURE 2. INFERTILITY TREATMENT MARKET MULTI-LANGUAGE
• FIGURE 3. INFERTILITY TREATMENT MARKET RESEARCH PROCESS
• FIGURE 4. INFERTILITY TREATMENT MARKET SIZE, 2024 VS 2030
• FIGURE 5. GLOBAL INFERTILITY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 6. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
• FIGURE 9. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
• FIGURE 11. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2024 VS 2030 (%)
• FIGURE 13. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
• FIGURE 15. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 17. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
• FIGURE 19. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 24. INFERTILITY TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 25. INFERTILITY TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. INFERTILITY TREATMENT MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL INFERTILITY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. INFERTILITY TREATMENT MARKET DYNAMICS
• TABLE 7. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY CRYOSYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY GAS ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY INCUBATORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY LASER SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY MICROMANIPULATOR SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY MICROSCOPES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY OVUM ASPIRATION PUMPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY SPERM ANALYZER SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY SPERM SEPARATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY CRYOPRESERVATION MEDIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY CULTURE MEDIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY INTRACERVICAL INSEMINATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY INTRATUBAL INSEMINATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY INTRAUTERINE INSEMINATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY EMBRYO CRYOPRESERVATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION (IVF), BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY INTRACYTOPLASMIC SPERM INJECTION (ICSI), BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY PREIMPLANTATION GENETIC DIAGNOSIS (PGD), BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY CLOMIPHENE CITRATE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 39. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY GONADOTROPINS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 40. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY LETROZOLE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 41. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY METFORMIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 42. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
• TABLE 43. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 44. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY HYSTEROSCOPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 45. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY LAPAROSCOPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 46. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY MYOMECTOMY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 47. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY VARICOCELE REPAIR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 48. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY VARICOCELECTOMY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 49. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
• TABLE 50. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 51. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 52. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY HYSTEROSALPINGOGRAPHY (HSG), BY REGION, 2018-2030 (USD MILLION)
• TABLE 53. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY OVULATION TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 54. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
• TABLE 55. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 56. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY BLOOD TESTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 57. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY SEMEN ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 58. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY TESTICULAR BIOPSY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 59. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
• TABLE 60. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 61. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY CRYOBANKS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 62. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 63. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 64. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 65. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 66. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 67. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 68. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 69. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
• TABLE 70. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
• TABLE 71. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
• TABLE 72. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
• TABLE 73. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 74. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
• TABLE 75. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
• TABLE 76. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 77. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 78. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 79. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 80. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 81. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 82. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
• TABLE 83. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
• TABLE 84. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
• TABLE 85. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
• TABLE 86. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 87. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
• TABLE 88. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
• TABLE 89. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 90. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 91. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 92. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 93. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 94. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
• TABLE 95. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
• TABLE 96. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
• TABLE 97. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
• TABLE 98. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 99. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
• TABLE 100. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
• TABLE 101. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 102. CANADA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 103. CANADA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 104. CANADA INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 105. CANADA INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 106. CANADA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
• TABLE 107. CANADA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
• TABLE 108. CANADA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
• TABLE 109. CANADA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
• TABLE 110. CANADA INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 111. CANADA INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
• TABLE 112. CANADA INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
• TABLE 113. CANADA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 114. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 115. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 116. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 117. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 118. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
• TABLE 119. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
• TABLE 120. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
• TABLE 121. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
• TABLE 122. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 123. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
• TABLE 124. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
• TABLE 125. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 126. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 127. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 128. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 129. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 130. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
• TABLE 131. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
• TABLE 132. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
• TABLE 133. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
• TABLE 134. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 135. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
• TABLE 136. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
• TABLE 137. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 138. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 139. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 140. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 141. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 142. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 143. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
• TABLE 144. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
• TABLE 145. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
• TABLE 146. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
• TABLE 147. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 148. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
• TABLE 149. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
• TABLE 150. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 151. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 152. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 153. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 154. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 155. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 156. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
• TABLE 157. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
• TABLE 158. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
• TABLE 159. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
• TABLE 160. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 161. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
• TABLE 162. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
• TABLE 163. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 164. CHINA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 165. CHINA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 166. CHINA INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 167. CHINA INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 168. CHINA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
• TABLE 169. CHINA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
• TABLE 170. CHINA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
• TABLE 171. CHINA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
• TABLE 172. CHINA INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 173. CHINA INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
• TABLE 174. CHINA INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
• TABLE 175. CHINA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 176. INDIA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 177. INDIA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 178. INDIA INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 179. INDIA INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 180. INDIA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
• TABLE 181. INDIA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
• TABLE 182. INDIA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
• TABLE 183. INDIA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
• TABLE 184. INDIA INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 185. INDIA INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
• TABLE 186. INDIA INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
• TABLE 187. INDIA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 188. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 189. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 190. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 191. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 192. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
• TABLE 193. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
• TABLE 194. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
• TABLE 195. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
• TABLE 196. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 197. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
• TABLE 198. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
• TABLE 199. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 200. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 201. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 202. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 203. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 204. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
• TABLE 205. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
• TABLE 206. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
• TABLE 207. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
• TABLE 208. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 209. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
• TABLE 210. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
• TABLE 211. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 212. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 213. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 214. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 215. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 216. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
• TABLE 217. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
• TABLE 218. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
• TABLE 219. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
• TABLE 220. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 221. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
• TABLE 222. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
• TABLE 223. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 224. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 225. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 226. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 227. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 228. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
• TABLE 229. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
• TABLE 230. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
• TABLE 231. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
• TABLE 232. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 233. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
• TABLE 234. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
• TABLE 235. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 236. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 237. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 238. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 239. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 240. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
• TABLE 241. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
• TABLE 242. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
• TABLE 243. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
• TABLE 244. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 245. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
• TABLE 246. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
• TABLE 247. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 248. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 249. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 250. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 251. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 252. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
• TABLE 253. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
• TABLE 254. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
• TABLE 255. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
• TABLE 256. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 257. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
• TABLE 258. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
• TABLE 259. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 260. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 261. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 262. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 263. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 264. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
• TABLE 265. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
• TABLE 266. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
• TABLE 267. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
• TABLE 268. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 269. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
• TABLE 270. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
• TABLE 271. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 272. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 273. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 274. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 275. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 276. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
• TABLE 277. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
• TABLE 278. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
• TABLE 279. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
• TABLE 280. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 281. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
• TABLE 282. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
• TABLE 283. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 284. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 285. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 286. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 287. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 288. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
• TABLE 289. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
• TABLE 290. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
• TABLE 291. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
• TABLE 292. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 293. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
• TABLE 294. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
• TABLE 295. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 296. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 297. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 298. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 299. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 300. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
• TABLE 301. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
• TABLE 302. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
• TABLE 303. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
• TABLE 304. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 305. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
• TABLE 306. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
• TABLE 307. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 308. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 309. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 310. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 311. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 312. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 313. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
• TABLE 314. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
• TABLE 315. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
• TABLE 316. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
• TABLE 317. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 318. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
• TABLE 319. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
• TABLE 320. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 321. EGYPT INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 322. EGYPT INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-

The Infertility Treatment Market was valued at USD 5.93 billion in 2024 and is projected to grow to USD 6.58 billion in 2025, with a CAGR of 11.32%, reaching USD 11.30 billion by 2030.

In today's rapidly advancing medical field, infertility treatment has emerged as a beacon of hope for countless individuals and families. The market is not just expanding in terms of size, but also evolving in complexity due to cutting-edge innovations and enhanced patient care standards. Over the past several years, the convergence of new technologies and a deeper understanding of reproductive health has transformed diagnostic and treatment practices. This transformation is evident in the increased adoption of minimally invasive procedures, optimized laboratory techniques, and enhanced monitoring tools that have significantly boosted success rates in treatment cycles.

The global focus on personalization and improved patient experiences has led to a more holistic approach in addressing infertility. Health care providers and researchers are continually exploring integrated treatment pathways that combine traditional methods with novel scientific discoveries, resulting in increased efficacy and reduced emotional as well as financial burdens for patients. As we delve further, this executive summary highlights critical market trends, outlines key segmentation findings, and presents actionable recommendations that collectively bring clarity to this dynamic sector.

Transformative Shifts Redefining Infertility Treatment

Recent years have witnessed transformative shifts that are reshaping the infertility treatment landscape. Technological adoption in areas such as imaging systems and laser equipment has paved the way for more precise diagnostics and targeted interventions. Modern cryosystems and advanced incubator designs have revolutionized the preservation processes, ensuring higher success rates during subsequent treatment cycles. Such advancements have been bolstered by a greater emphasis on patient-centric care, with clinicians favoring techniques that minimize discomfort and shorten recovery times.

Furthermore, regulatory frameworks and increased funding for research have accelerated the adoption of innovative treatment approaches. As emerging technologies integrate into routine clinical practice, there is a visible transition toward highly specialized diagnostic tools and therapies. This shift is not only elevating the quality of patient care but also triggering competitive dynamic changes within the industry. Decision-makers now find themselves at the crossroads of embracing technological evolution while ensuring operational excellence, making it imperative to adapt strategically to the current market demands.

In-depth Segmentation Insights Shaping the Market

A closer assessment of the market reveals clear segmentation patterns that drive strategic decision-making in the infertility treatment industry. When examining the product type, the focus is placed on Accessories, Equipment, and Media & Consumables. Equipment, in particular, has been studied in comprehensive detail, with special attention given to Cryosystems, Gas Analyzers, Imaging Systems, Incubators, Laser Systems, Micromanipulator Systems, Microscopes, Ovum Aspiration Pumps, Sperm Analyzer Systems, and Sperm Separation Devices. Additionally, Media & Consumables such as Cryopreservation Media and Culture Media play a pivotal role in maintaining high quality and viability during treatment procedures.

Segmentation based on treatment type uncovers further granular insights. The market analysis explores Artificial Insemination with its specifically studied Intracervical, Intratubal, and Intrauterine methods. Assisted Reproductive Technology (ART) is examined through the lenses of Embryo Cryopreservation, In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), and Preimplantation Genetic Diagnosis (PGD). Equally, fertility treatments include targeted fertility drugs, comprising Clomiphene Citrate, Gonadotropins, Letrozole, and Metformin, as well as fertility surgeries such as Hysteroscopy, Laparoscopy, Myomectomy, Varicocele Repair, and Varicocelectomy. Further segmentation based on diagnosis distinguishes the subtle differences between Female Infertility, evaluated through Hysterosalpingography and Ovulation Testing, and Male Infertility, assessed with Blood Tests, Semen Analysis, and Testicular Biopsy, while the end user spectrum covers Cryobanks, Fertility Clinics, Hospitals, and Research Institutes. This comprehensive segmentation framework provides a robust basis for market understanding and strategic planning.

Based on Product Type, market is studied across Accessories, Equipment, and Media & Consumables. The Equipment is further studied across Cryosystems, Gas Analyzers, Imaging Systems, Incubators, Laser Systems, Micromanipulator Systems, Microscopes, Ovum Aspiration Pumps, Sperm Analyzer Systems, and Sperm Separation Devices. The Media & Consumables is further studied across Cryopreservation Media and Culture Media.

Based on Treatment Type, market is studied across Artificial Insemination, Assisted Reproductive Technology (ART), Fertility Drugs, and Fertility Surgeries. The Artificial Insemination is further studied across Intracervical Insemination, Intratubal Insemination, and Intrauterine Insemination. The Assisted Reproductive Technology (ART) is further studied across Embryo Cryopreservation, In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), and Preimplantation Genetic Diagnosis (PGD). The Fertility Drugs is further studied across Clomiphene Citrate, Gonadotropins, Letrozole, and Metformin. The Fertility Surgeries is further studied across Hysteroscopy, Laparoscopy, Myomectomy, Varicocele Repair, and Varicocelectomy.

Based on Diagnosis, market is studied across Female Infertility and Male Infertility. The Female Infertility is further studied across Hysterosalpingography (HSG) and Ovulation Testing. The Male Infertility is further studied across Blood Tests, Semen Analysis, and Testicular Biopsy.

Based on End User, market is studied across Cryobanks, Fertility Clinics, Hospitals, and Research Institutes.

Key Regional Insights Across Diverse Global Markets

The global infertility treatment market is characterized by remarkable regional diversity, with variations in market maturity, technological readiness, and regulatory support across different territories. In the Americas, robust healthcare infrastructures and a strong emphasis on research innovation have led to early adoption of technologies and advanced treatment protocols, facilitating enhanced patient outcomes. Across Europe, Middle East & Africa, a blend of legacy medical practices and modern breakthroughs creates an ecosystem that values both traditional empathy and high-end technological contributions to infertility care.

In the Asia-Pacific region, accelerated economic development and increasing awareness of reproductive health issues have spurred significant investments in state-of-the-art facilities and treatment centers. This region is witnessing not only rapid growth in patient numbers but also the emergence of local players who are keen to implement innovative methodologies. These regional insights emphasize the importance of localized strategies that consider cultural nuances, economic variables, and infrastructural variations, enabling market players to tailor their offerings and optimize operational effectiveness on both a macro and micro level across the global landscape.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Competitive Landscape and Key Company Insights

The competitive dynamics in the infertility treatment market are defined by the presence of several leading and influential companies that drive innovation and set industry benchmarks. Major players such as AbbVie Inc. and Bayer AG are forging ahead by investing in research and development, helping to pioneer cutting-edge treatment methodologies. Specialized institutions like City Fertility Centre and CooperSurgical, Inc. provide customized solutions that cater to diverse patient needs and clinical requirements. Innovative firms such as Cryoport Systems, LLC. and Embryolab, along with EQUIPO IVI, S. L., are continuously refining technologies that enhance operational efficiency and treatment accuracy.

Ferring International Center S.A. and FUJIFILM Irvine Scientific, Inc. further contribute to the competitive landscape with robust portfolios that encompass state-of-the-art equipment and consumables. Companies including Genea Group, IVI AMERICA, LLC, and Merck KGaA have established themselves as thought leaders by integrating advanced research into clinical applications. Notably, specialized clinics and institutes like Monash IVF, New Hope Fertility Clinic, Nova IVF Fertility, and NOW-fertility SA, along with dedicated healthcare providers such as Ovum Woman and Child Specialty Hospital, ReproTech LLC, Seegene, Inc., TMRW Life Sciences, Inc., and Vitrolife Sweden AB, continue to shape the market intricately through comprehensive, patient-focused solutions. Their contributions not only drive innovation but also set a high standard for clinical excellence and service delivery.

The report delves into recent significant developments in the Infertility Treatment Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Bayer AG, City Fertility Centre, CooperSurgical, Inc., Cryoport Systems, LLC., Embryolab, EQUIPO IVI, S. L., Ferring International Center S.A., FUJIFILM Irvine Scientific, Inc., Genea Group, IVI AMERICA, LLC, Merck KGaA, Monash IVF, New Hope Fertility Clinic, Nova IVF Fertility, NOW-fertility SA, Ovum Woman and Child specialty Hospital, ReproTech LLC, Seegene, Inc., TMRW Life Sciences, Inc., and Vitrolife Sweden AB. Actionable Recommendations for Industry Leaders

For industry leaders navigating the challenging but promising infertility treatment landscape, several key recommendations emerge from the analysis. First, continually invest in research and development initiatives to keep pace with advancing technologies and evolving clinical methods. Emphasis should be placed on integrating comprehensive diagnostic systems and ensuring that treatment processes remain patient-centric. Leaders are encouraged to form strategic alliances with technology providers and research institutions as a way to harness cutting-edge innovations while mitigating risks associated with rapid technological changes.

It is crucial to adopt a multi-faceted market approach that considers diverse segmentation factors-from product types and treatment modalities to diagnostic tools and end user needs. Firms should undertake regular competitive benchmarking to align their portfolios with global best practices, while also adapting to regional market dynamics. Enhancing regulatory compliance and focusing on operational efficiency will serve as catalysts for sustained growth. By proactively addressing new market challenges and capitalizing on emerging opportunities, industry leaders can solidify their position and drive long-term value in this evolving sector.

Conclusion and Future Outlook for Infertility Treatment

In conclusion, the infertility treatment market is undergoing a period of significant transformation. The interplay of innovative technologies, targeted segmentation strategies, and rapid regional growth presents abundant opportunities and challenges alike. As advancements in diagnostic and treatment methods continue to evolve, stakeholders must maintain agility and adaptability in order to remain competitive. The depth of segmentation based on product type, treatment type, diagnosis, and end user affirm the complexity of the market, while also highlighting key areas for strategic focus and growth.

Looking forward, an integrated approach that combines technological innovation with strategic market positioning is critical. Insights derived from both regional trends and competitive analyses offer invaluable guidance for shaping the future trajectory of infertility treatment. By embracing new methodologies and fostering collaborative partnerships, the industry can continue to enhance patient outcomes, improve technological adoption, and ultimately deliver more effective and comprehensive care solutions. The roadmap outlined herein serves as a foundation for sustained progress and market leadership in the evolving global healthcare landscape.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing prevalence of infertility due to lifestyle changes and delayed parenthood
    • 5.1.1.2. Rising investments and funding in infertility treatment research and development
    • 5.1.1.3. Increasing awareness and acceptance of assisted reproductive technologies
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with infertility treatments and variability in infertility treatment protocols
  • 5.1.3. Opportunities
    • 5.1.3.1. Advancement of personalized medicine approaches tailored to individual patient fertility profiles
    • 5.1.3.2. Telemedicine implementation to expand infertility consultations and treatment accessibility
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of awareness and education about infertility treatment
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product Type: Rising significance of equipment in infertility treatment
  • 5.2.2. End User: Growing preference for fertility clinics due to its comprehensive range of infertility treatments
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Infertility Treatment Market, by Product Type

• 6.1. Introduction
• 6.2. Accessories
• 6.3. Equipment
  • 6.3.1. Cryosystems
  • 6.3.2. Gas Analyzers
  • 6.3.3. Imaging Systems
  • 6.3.4. Incubators
  • 6.3.5. Laser Systems
  • 6.3.6. Micromanipulator Systems
  • 6.3.7. Microscopes
  • 6.3.8. Ovum Aspiration Pumps
  • 6.3.9. Sperm Analyzer Systems
  • 6.3.10. Sperm Separation Devices
• 6.4. Media & Consumables
  • 6.4.1. Cryopreservation Media
  • 6.4.2. Culture Media

7. Infertility Treatment Market, by Treatment Type

• 7.1. Introduction
• 7.2. Artificial Insemination
  • 7.2.1. Intracervical Insemination
  • 7.2.2. Intratubal Insemination
  • 7.2.3. Intrauterine Insemination
• 7.3. Assisted Reproductive Technology (ART)
  • 7.3.1. Embryo Cryopreservation
  • 7.3.2. In Vitro Fertilization (IVF)
  • 7.3.3. Intracytoplasmic Sperm Injection (ICSI)
  • 7.3.4. Preimplantation Genetic Diagnosis (PGD)
• 7.4. Fertility Drugs
  • 7.4.1. Clomiphene Citrate
  • 7.4.2. Gonadotropins
  • 7.4.3. Letrozole
  • 7.4.4. Metformin
• 7.5. Fertility Surgeries
  • 7.5.1. Hysteroscopy
  • 7.5.2. Laparoscopy
  • 7.5.3. Myomectomy
  • 7.5.4. Varicocele Repair
  • 7.5.5. Varicocelectomy

8. Infertility Treatment Market, by Diagnosis

• 8.1. Introduction
• 8.2. Female Infertility
  • 8.2.1. Hysterosalpingography (HSG)
  • 8.2.2. Ovulation Testing
• 8.3. Male Infertility
  • 8.3.1. Blood Tests
  • 8.3.2. Semen Analysis
  • 8.3.3. Testicular Biopsy

9. Infertility Treatment Market, by End User

• 9.1. Introduction
• 9.2. Cryobanks
• 9.3. Fertility Clinics
• 9.4. Hospitals
• 9.5. Research Institutes

10. Americas Infertility Treatment Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Infertility Treatment Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Infertility Treatment Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2024
• 13.2. FPNV Positioning Matrix, 2024
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Bayer enters digital health collaboration with Impli to innovate infertility treatment
  • 13.3.2. Birla Fertility's key acquisition of IVF chain BabyScience signifies a robust expansion in India's growing infertility treatment sector
  • 13.3.3. Conduit Pharmaceuticals boosts portfolio with AstraZeneca's assets to tackle autoimmune disorders and infertility
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AbbVie Inc.
• 2. Bayer AG
• 3. City Fertility Centre
• 4. CooperSurgical, Inc.
• 5. Cryoport Systems, LLC.
• 6. Embryolab
• 7. EQUIPO IVI, S. L.
• 8. Ferring International Center S.A.
• 9. FUJIFILM Irvine Scientific, Inc.
• 10. Genea Group
• 11. IVI AMERICA, LLC
• 12. Merck KGaA
• 13. Monash IVF
• 14. New Hope Fertility Clinic
• 15. Nova IVF Fertility
• 16. NOW-fertility SA
• 17. Ovum Woman and Child specialty Hospital
• 18. ReproTech LLC
• 19. Seegene, Inc.
• 20. TMRW Life Sciences, Inc.
• 21. Vitrolife Sweden AB